A Follow-up Study of Cerebral Microbleeds in Patients Who Received Stents for Symptomatic Cerebral Artery Stenosis

作者：Gao, Yuyuan; Nie, Kun; Duan, Zhenpeng; Wang, Shuo; Ma, Guixian; Zhang, Xiong; Li, Changmao; Zhang, Yuhu; Dai, Chengbo^*; Wang, Lijuan^*

来源：Annals of Vascular Surgery, 2019, 58: 338-346.

DOI：10.1016/j.avsg.2018.11.031

• INTRACEREBRAL HEMORRHAGE
• AMYLOID ANGIOPATHY
• ISCHEMIC-STROKE
• RISK
• HYPERTENSION
• DISEASE
• BURDEN
• CHINA
• GUIDE

Background: The aims of this study were to explore (i) the dynamic changes in cerebral microbleeds (CMBs) in patients with symptomatic cerebral artery stenosis who received endovascular stent-assisted angioplasty and (ii) the risk factors associated with the new incidence of CMBs as well as whether CMBs increased the risk of vascular events in these patients.
Methods: Clinical information and magnetic resonance images were collected on admission and 3 months after endovascular stent-assisted angioplasty. Based on susceptibility-weighted imaging, the patients were divided into groups with or without newly developed CMBs, and between-group differences in risk factors were compared. We also compared whether CMBs increased the risk of vascular events among those patients.
Results: Seventy-three patients completed the relevant follow-up examinations. After an average follow-up period of 109 days, 7 (9.6%) patients showed new CMBs. A univariate analysis showed that the number of lacunar infarcts and the increase in systolic blood pressure were higher in patients with new CMBs than in those without new CMBs, and these differences were significant (P = 0.034, P = 0.001). Increased systolic blood pressure was an independent risk factor for developing new CMBs (P = 0.017).
Conclusions: CMBs may be a continuously progressing cerebral small-vessel disease. The newly developed CMBs in patients with intracranial and/or extracranial stents were associated with increased systolic blood pressure but not with the number of baseline CMBs.

• 出版日期2019-7
• 单位广东省人民医院